Anti-Factor VIII [EL-16]
AB04010-30.11-BT
ApplicationsFunctional Assay, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetF8
Overview
- SupplierAbsolute Antibody
- Product NameAnti-Factor VIII [EL-16]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds the C2 domain of the human factor VIII, a glycoprotein involved in blood coagulation. Factor VIII acts as a cofactor for factor IXa which converts factor X to the activated form Xa in the presence of calcium and phospholipids. Defects
- Application Supplier NoteThe inhibitory activity of this antibody against factor VIII was determined using a one-stage clotting assay. This antibody was capable of completely eliminating FVIII inhibition by CLB-CAg 117, a C2 domain directed anti-factor VIII antibody (PMID: 10627462).
- ApplicationsFunctional Assay, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDEL-16
- Gene ID2157
- Target nameF8
- Target descriptioncoagulation factor VIII
- Target synonymsAHF; antihemophilic factor; coagulation factor VIII; coagulation factor VIII A1 domain; coagulation factor VIII C2 domain; coagulation factor VIII, procoagulant component; coagulation factor VIIIc; DXS1253E; F8B; F8C; factor VIII F8B; FVIII; HEMA
- Protein IDP00451
- Protein NameCoagulation factor VIII
- Scientific DescriptionThis is a reformatted human scFv antibody, based on the original human scFv format, created for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203